APHL 2 LIMITED
Get an alert when APHL 2 LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£7.1m
-17.6% lowest in 3 filed years
Net assets
£73m
+45.2% highest in 3 filed years
Employees
116
+16% highest in 3 filed years
Profit before tax
£25m
-2.6% vs 2024
Watch the reel
Our short-form breakdown of APHL 2 LIMITED's latest filing
Aspire Pharma's holding company APHL 2 Limited posts a steady £118m turnover and £25m operating profit, while navigating post-Brexit regulations. But last year's £5.8m dividend? Gone. 💊
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £99,113,709 | £114,957,000 | £118,169,000 | +2.8% | |
| Operating profit | £21,215,504 | £25,527,000 | £24,960,000 | -2.2% | |
| Profit before tax | £21,315,824 | £25,764,000 | £25,096,000 | -2.6% | |
| Net profit | £20,528,903 | £23,928,000 | £22,699,000 | -5.1% | |
| Cash | £9,854,905 | £8,677,000 | £7,147,000 | -17.6% | |
| Total assets less current liabilities | £33,090,482 | £51,305,000 | £74,456,000 | +45.1% | |
| Net assets | £32,070,504 | £50,204,000 | £72,902,000 | +45.2% | |
| Equity | £32,070,504 | £50,204,000 | £72,902,000 | +45.2% | |
| Average employees | 79 | 100 | 116 | +16% | |
| Wages | £4,016,595 | £6,301,000 | £6,910,000 | +9.7% | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 21.4% | 22.2% | 21.1% | |
| Net margin | 20.7% | 20.8% | 19.2% | |
| Return on capital employed | 64.1% | 49.8% | 33.5% | |
| Gearing (liabilities / total assets) | 47.3% | 37.9% | 33.1% | |
| Current ratio | 1.87x | 2.05x | 1.99x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- TC Group
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that... may cast significant doubt on the group's and parent company's ability to continue as a going concern.”
Group structure
- APHL 2 LIMITED · parent
- Aspire Pharma Limited 100%
- Dermato Logical Limited 100%
- Cenote Pharma Limited 100%
- Aspire Pharma GmbH 100%
- APIE Limited 100%
- Charlwood Pharma Limited 100%
- Saint-Germain Pharma Limited 100%
Significant events
- “On 1 October 2025 Aspire Pharma Limited acquired 100% of the share capital of Charlwood Pharma Limited, a company registered in the UK.”
- “On 1 October 2025 Aspire Pharma Limited acquired 100% of the share capital of Saint-Germain Pharma Limited, a company registered in the UK.”
- “In February 2026, Aspire Pharma Limited completed the acquisition of all of the share capital in Caragen Limited, a company incorporated in the Republic of Ireland, for consideration of €19,909,622.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BUCKLEY, Gary David | Secretary | 2020-06-15 | — | — |
| BUCKLEY, Gary David | Director | 2020-06-15 | Feb 1986 | British |
| CONDON, Richard Michael | Director | 2023-04-28 | Aug 1976 | British |
| MAY, Jonathan Charles | Director | 2020-06-15 | Apr 1970 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FRASER-PYE, Jacqueline Elizabeth | Secretary | 2019-09-19 | 2022-03-11 |
| ROBERTS, Debra Joy | Secretary | 2019-09-19 | 2020-05-31 |
| FRASER-PYE, Graham Julian | Director | 2018-08-23 | 2021-09-03 |
| JACOBSON, Ian | Director | 2019-09-19 | 2021-09-03 |
| PODOLSKY, Craig | Director | 2020-06-15 | 2021-09-03 |
| ROBERTS, Debra Joy | Director | 2019-09-19 | 2020-05-30 |
| ROBERTS, Mark Derek | Director | 2019-09-19 | 2021-09-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Aspire Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-09-03 | Ceased 2022-11-28 |
| Ian Jacobson | Individual | Shares 25–50%, Voting 25–50% | 2019-09-19 | Ceased 2021-09-03 |
| Mr Graham Julian Fraser-Pye | Individual | Shares 25–50%, Voting 25–50% | 2018-08-23 | Ceased 2021-09-03 |
Filing timeline
Last 20 of 59 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-01-10 MA Memorandum articles
- 2024-01-10 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-29 | AA | accounts | Accounts with accounts type group | |
| 2026-08-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-03 | AA | accounts | Accounts with accounts type group | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-25 | AA | accounts | Accounts with accounts type group | |
| 2024-01-10 | MA | incorporation | Memorandum articles | |
| 2024-01-10 | RESOLUTIONS | resolution | Resolution | |
| 2023-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-10 | AA | accounts | Accounts with accounts type group | |
| 2023-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-06 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2023-02-06 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2022-12-06 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2022-12-06 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-08-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-07-08 | AA | accounts | Accounts with accounts type group | |
| 2022-03-11 | TM02 | officers | Termination secretary company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.